State of the Art Technology

We are pleased to announce that Greater Gaston Endoscopy Center has acquired the new Olympus EVIS EXERA III video endoscopy platform. Endoscopy systems, through the collaborative use of a video processor, light source, endoscope and monitor, enable physicians to peer inside the human body to diagnose, detect and treat gastrointestinal (GI) diseases and other conditions.

The new EVIS EXERA III system brings enhanced image quality, added brightness and several key technologies such as HDTV for superior clarity. The next-generation Narrow Band Imaging allows for enhanced observation of mucosal tissue; and dual-focus capabilities that will allow our physicians to switch the depth of field from normal focus to near focus for more detailed observation of suspected lesions. These new technologies will help our physicians provide patients with more accurate and earlier diagnoses.

Utilizing this EVIS EXERA III endoscopy system will help us to meet new government healthcare reform requirements aimed at improving quality of care, decreasing costs, and enhancing patient satisfaction. Greater Gaston Endoscopy Center has built a computerized network that joins the endoscopy equipment, the electronic medical record software and patient monitoring equipment together. Patient reports can be immediately sent to referring physicians, laboratory and anesthesia providers at the conclusion of each procedure.

Colonoscopy plays a vital role in detecting, diagnosing and treating diseases of the colon, including polyps and colorectal cancers. According to the American Cancer Society, Colorectal cancer is the third leading cause of cancer-related deaths in the United States when men and women are considered separately, and the second leading cause when both sexes are combined. It is expected to cause about 49,700 deaths during 2015. Thanks in part to advances in colonoscopy; the death rate from colorectal cancer has been dropping in both men and women for more than 20 years.

(Image Source: Evis Exera III:

back to top